tiprankstipranks
Trending News
More News >
Genmab A/S (GMAB)
NASDAQ:GMAB
US Market

Genmab (GMAB) Technical Analysis

Compare
635 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Genmab A/S’s (GMAB) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Genmab A/S is a Sell.
Genmab A/S’s (GMAB) 20-Day exponential moving average is 21.17, while Genmab A/S’s (GMAB) share price is $21.4, making it a Buy.
Genmab A/S’s (GMAB) 50-Day exponential moving average is 21.04, while Genmab A/S’s (GMAB) share price is $21.4, making it a Buy.

Genmab (GMAB) Pivot Points

Jul 12, 2025, 09:49 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
21.26
21.39
21.63
21.76
22.00
22.13
22.36
Fibonacci
21.39
21.54
21.62
21.76
21.90
21.99
22.13
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Genmab (GMAB) Moving Averages

Jul 12, 2025, 09:49 PM
Period
Simple
Exponential
MA5
21.32Buy
21.34Buy
MA10
20.92Buy
21.18Buy
MA20
21.27Buy
21.17Buy
MA50
21.05Buy
21.04Buy
MA100
20.82Buy
21.08Buy
MA200
21.25Buy
22.12Sell
Genmab A/S’s (GMAB) 10-Day exponential moving average is 21.18, while Genmab A/S’s (GMAB) share price is $21.4, making it a Buy.
Genmab A/S’s (GMAB) 100-Day exponential moving average is 21.08, while Genmab A/S’s (GMAB) share price is $21.4, making it a Buy.
Genmab A/S’s (GMAB) stock price is $21.4 and Genmab A/S’s (GMAB) 50-day simple moving average is 21.05, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $21.4 and Genmab A/S’s (GMAB) 100-day simple moving average is 20.82, creating a Buy signal.
Genmab A/S’s (GMAB) stock price is $21.4 and Genmab A/S’s (GMAB) 200-day simple moving average is 21.25, creating a Buy signal.

Genmab (GMAB) Technical Indicators

Jul 12, 2025, 09:49 PM
Name
Value
Implied Action
RSI (14)
52.83
Neutral
STOCH (9,6)
87.79
Sell
STOCHRSI (14)
82.79
Sell
MACD (12,26)
>-0.01
Sell
ADX (14)
17.51
Buy
Williams %R
-29.77
Buy
CCI (14)
17.27
Neutral
ATR (14)
0.48
-
Ultimate Oscillator
59.13
Neutral
ROC
1.13
Buy
Genmab A/S’s (GMAB) Relative Strength Index (RSI) is 52.83, creating a Neutral signal.
Genmab A/S’s (GMAB) Trend Strength Indicator (ADX) is 17.51, creating a Buy signal.
Genmab A/S’s (GMAB) Commodity Channel Index (CCI) is 17.27, creating a Neutral signal.
Genmab A/S’s (GMAB) Price Rate of Change (ROC) is 1.13, creating a Buy signal.

FAQ

Is GMAB a Buy, Hold, or Sell?
Based on GMAB’s technical indicators, GMAB is a Buy.
    What is GMAB’s RSI (14)?
    GMAB’s RSI (14) is 52.83, which suggests GMAB is a Neutral.
      What is GMAB’s MACD?
      GMAB’s MACD is >-0.01, which suggests GMAB is a Sell.
        What is GMAB’s 5-day moving average?
        GMAB’s 5-day moving average is 21.32, which suggests GMAB is a Buy.
          What is GMAB’s 20-day moving average?
          GMAB 20-day moving average is 21.27, which suggests GMAB is a Buy.
            What is GMAB’s 50-day moving average?
            GMAB’s 50-day moving average is 21.05, which suggests GMAB is a Buy.
              What is GMAB’s 200-day moving average?
              GMAB’s 200-day moving average is 21.25, which suggests GMAB is a Buy.
                What is GMAB’s Williams % R (14)?
                GMAB’s Williams % R (14) is -29.77, which suggests GMAB is a Buy.
                  What is GMAB’s CCI (14)?
                  GMAB’s CCI (14) is 17.27, which suggests GMAB is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis